Haemonetics Corp. (HAE) reported first quarter EPS of $0.59 Friday morning, which beat the consensus estimate of $0.54. The company now expects to report full year EPS of $2.33 to $2.43, compared to the consensus estimate of $2.36.
Haemonetics gapped up Friday and rose sharply in early trade, to close higher by $3.07 at $61.13 on above average volume. The stock has been climbing for the last 3 weeks and closed at a 7-month high.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.